The Influence of Physical Activity on Inflammatory Markers, Intestinal Microbiota Composition and Disease Activity in Inflammatory Bowel Disease
Authors:
- Paulina JakubczykPJPaulina Jakubczyk
- Piotr WideraPWPiotr Widera
- Justyna HelisJHJustyna Helis
- Maciej MichalikMMMaciej Michalik
- Aleksandra BuczekABAleksandra Buczek
- Hubert BigajskiHBHubert Bigajski
- Aleksandra BanaśABAleksandra Banaś
- Olga BilczewskaOBOlga Bilczewska
- Wiktoria JanikWJWiktoria Janik
- Marta HandschuhMHMarta Handschuh
Open Access
- 20 January 2025
- journal article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57087
Abstract
Aim of the StudyThis review investigates the relationship between physical activity and inflammatory bowel disease (IBD), focusing on inflammatory markers, gut microbiota composition, and disease activity. The objective is to examine how exercise intensities influence inflammation, microbial diversity, and patient outcomes for IBD management. Materials and MethodsA literature review synthesized peer-reviewed studies from 2010-2024 using PubMed, Scopus, and Embase databases, examining physical activity effects on inflammatory markers, gut microbiota, and clinical outcomes in IBD patients. Inclusion criteria emphasized human studies, excluding research unrelated to IBD or focused on animal models. State of KnowledgeModerate-intensity aerobic and resistance exercises reduce systemic inflammatory markers, (CRP and cytokines) and enhance gut microbiota diversity, increasing anti-inflammatory species. Low-to-moderate intensity activities improve quality of life in IBD patients. Exercise supports intestinal barrier integrity through mucin production and fatty acid synthesis. High-intensity exercise can worsen inflammation, necessitating tailored protocols. ConclusionsPhysical activity is a promising adjunctive therapy in IBD management. Moderate-intensity programs effectively maintain remission and enhance outcomes. Future research should focus on longitudinal studies, advanced omics technologies, and combined approaches with dietary and pharmacological therapies.Keywords
This publication has 51 references indexed in Scilit:
- Global, regional, and national burden of inflammatory bowel disease, 1990–2021: Insights from the global burden of disease 2021International Journal of Colorectal Disease, 2024
- The impact of physical exercise on health-related quality of life in inflammatory bowel diseaseCochrane Database of Systematic Reviews, 2023
- Unlocking a novel determinant of athletic performance: The role of the gut microbiota, short-chain fatty acids, and “biotics” in exerciseJournal of Sport and Health Science, 2022
- Reply to Meshkini et al.European Journal of Clinical Nutrition, 2021
- Evidence-based clinical practice guidelines for inflammatory bowel disease 2020Journal of Gastroenterology, 2021
- Association of Healthy Lifestyle With Years Lived Without Major Chronic DiseasesJAMA Internal Medicine, 2020
- Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolismNature Medicine, 2019
- Living with Inflammatory Bowel Disease: A review of qualitative research studiesInternational Journal of Nursing Studies, 2018
- ACG Clinical Guideline: Management of Crohn's Disease in AdultsAmerican Journal of Gastroenterology, 2018
- Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctionsExperimental & Molecular Medicine, 2018